Search Details

Word: allergan (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

Here's the latest wrinkle in skin care: Elizabeth Arden, the cosmetics giant, and Allergan, the $2.2 billion maker of Botox, have teamed to bring you the first-ever cosmetic version of a pharmaceutical product. Until now, Prevage, Allergan's topical antiaging treatment, has been available for purchase only at a dermatologist's office or medical spa. By December, a creamier and less concentrated version of the wrinkle cream will be on sale at select U.S. department stores ($150 for 1.7 oz.). Overseas customers will be able to find it beginning in March. This cosmeceutical alliance is a harbinger...

Author: /time Magazine | Title: Wrinkle Free for $150 | 11/20/2005 | See Source »

...world of aging boomers, both companies see vigorous opportunity. Says Allergan vice president Bob Rhatigan: "Our product [will get] more brand exposure." For the $920 million Elizabeth Arden, which two weeks ago cut its 2006 fiscal earnings forecast because of depressed consumer spending in Europe, Prevage could help it break through the cluttered $7 billion antiaging skin-care market--and give its sagging profits a lift...

Author: /time Magazine | Title: Wrinkle Free for $150 | 11/20/2005 | See Source »

StriVectin is either the latest fad in that movement or an antiaging silver bullet, depending on whom you ask. But in either case, it is clearly one of the most talked about new products in the industry, roiling competitors, realigning expectations and even prompting lawsuits--from Botox maker Allergan, which disputes StriVectin's advertising claims, and from StriVectin itself, against alleged copycat marketers pushing similarly named knock-offs. Priced at a hefty $135 per 6-oz. tube, StriVectin, made by privately held Klein-Becker, a division of Salt Lake City, Utah-- based weight-loss-supplement maker Basic Research, last year...

Author: /time Magazine | Title: Marketing: The War on Wrinkles | 4/3/2005 | See Source »

Perhaps most important, though, is the Botox issue. Even as Allergan's litigation with Klein-Becker about StriVectin's "Better than Botox?" ads is pending, the Food and Drug Administration has warned that StriVectin might be reclassified as a drug (which Klein-Becker is seeking to avoid). At the same time, other cosmetics competitors have jumped on the opportunity to compare themselves to Botox. Estée Lauder's Perfectionist is promoted in its ads as the ideal cream "for every woman who says no to Botox"; Avon's Anew Clinical Deep Crease Concentrate jabs at Botox with the line, "look...

Author: /time Magazine | Title: Marketing: The War on Wrinkles | 4/3/2005 | See Source »

...CLEARED. ALLERGAN, a California-based pharmaceutical company, and dermatologist ARNOLD KLEIN, 59; of charges that Klein poisoned the wife of former movie-studio head Mike Medavoy with Allergan's Botox injections. During the five-week trial, Irena Medavoy alleged that she became ill after Klein, who was an Allergan consultant, used the company's Botox to treat her migraine headaches. A jury rejected the malpractice claim...

Author: /time Magazine | Title: Milestones Oct. 18, 2004 | 10/18/2004 | See Source »

Previous | 1 | 2 | 3 | 4 | Next